Twitter | Search | |
MASC Trials
Melanoma and Skin Cancer Trials Ltd is a Collaborative Clinical Trials Group & conducts worldwide investigator-led clinical trials for melanoma & skin cancers.
280
Tweets
496
Following
233
Followers
Tweets
MASC Trials Aug 18
Click on the link to ensure you do not miss out on relevant and interesting upcoming events in the field of melanoma and skin cancer:
Reply Retweet Like
MASC Trials Aug 12
An interesting paper highlighting the potential future of screening
Reply Retweet Like
MASC Trials retweeted
Melanoma Australia Aug 12
Melbourne Patient Information Forum. Come and join us on Wed 25 Sep, 6pm to 9pm to hear from expert melanoma clinicians and listen to one pt’s story. Guest speakers - Prof Michael Henderson and Registration essential.
Reply Retweet Like
MASC Trials Aug 11
This paper highlights the importance of mandating the collection of blood to measure ctDNA in our protocols, such as in the currently recruiting 01.15 CHARLI trial and soon to be activated 10.17 GoTHAM trial
Reply Retweet Like
MASC Trials retweeted
Melanoma Australia Aug 8
Many thanks to our members for participating and & This survey & resultant I-MOVE trial demonstrates the value of collaborative *consumer initiated* studies assessing the impact of treatment on pts’ lifestyles when their experiences are collated
Reply Retweet Like
MASC Trials Aug 8
The survey discussed in this paper was integral to the development of the I-Move trial which is exploring the impact of exercise on fatigue in patients receiving immunotherapy
Reply Retweet Like
MASC Trials retweeted
A/Prof Haryana Dhillon Aug 5
If you are interested to read the statistical analysis plan for the of whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients you can access here:
Reply Retweet Like
MASC Trials Aug 5
To ensure robust & transparent analysis of clinical trial , a Statistical Analysis Plan is of utmost importance. The stats plan for the 01.07 WBRTMel trial has recently been published in Trials Journal and can be accessed via this link:
Reply Retweet Like
MASC Trials Aug 5
This week's bulletin details important upcoming events & conferences, highlights the ClinTrial Refer app and links to an interesting report regarding consumer involvement in clinical trials
Reply Retweet Like
MASC Trials retweeted
COSA Jul 29
abstract submissions close in 2 weeks. Check out breakfast sessions with and 12-14 November 2019 @AdleConv
Reply Retweet Like
MASC Trials retweeted
The Australasian Ocular Melanoma Alliance Jul 22
To learn more about the international uveal melanoma registry, watch A/Prof Anthony Joshua's presentation given at the AOMA Summit in May of this year:
Reply Retweet Like
MASC Trials retweeted
ACTA Jul 22
Just released ACTA Consumer Involvement in Clinical Trials: Consultation Report . Investigator-led research environment clearly values consumer engagement across a range of activities. Proud to be part of this project
Reply Retweet Like
MASC Trials Jul 21
MASC Trials are proud to be working with A/Prof Anthony Joshua to co-ordinate the Australian component of the international registry
Reply Retweet Like
MASC Trials Jul 20
This is an interesting group of stats based on the American population. Although incidence is rising in males and females, it is heartening to see the downward trend in death rates for both genders
Reply Retweet Like
MASC Trials retweeted
Professor Richard Scolyer Jul 13
Little known re risk developing in lentigo maligna (LM). In prospective popul-based // study, we est risk is 3.5%/year. This equates to avge time for LM to progress to LMM of 28.3 years. . see PMID: 31095041
Reply Retweet Like
MASC Trials Jul 9
MASC Trials Board Director Prof Peter Soyer speaks about the aim of achieving ‘a world without ’ and measures underway to reach this goal.
Reply Retweet Like
MASC Trials retweeted
Alison Button-Sloan Jun 29
Pleased to say Chair , Board, clinicians, CEO and team all engage with consumer/patient advocates at a high level via their involvement with the Australian Melanoma Consumer Alliance.
Reply Retweet Like
MASC Trials retweeted
H. Peter Soyer Jun 22
A plea for the relevance of clinical information for the histopathologic diagnosis of melanocytic skin lesions!
Reply Retweet Like
MASC Trials retweeted
Melanoma Australia Jun 23
Brisbane Melanoma Patient Information Forum. Come and join us on Thurs 25 July, 6pm to 9pm to hear from expert melanoma clinicians including patients talk about their experiences. Registration essential.
Reply Retweet Like
MASC Trials Jun 19
The importance of clinical trials such as 01.07 WBRTMel & forums such as at which to share knowledge, is highlighted in this article. can result in a change in practice for treating patients. Well done to all those involved
Reply Retweet Like